Innoviva, Inc.
DE ˙ DB ˙ US45781M1018
19,20 € ↑0,70 (3,78%)
2026-06-04
DEL PRIS
SecurityDE:HVE / Innoviva, Inc.
InstitutionPrincipal Financial Group Inc
Latest Disclosed Ownership418,731 shares
Latest Disclosed Value $ 9,756,433
Principal Financial Group Inc reports 23.48% increase in ownership of HVE / Innoviva, Inc.

On May 4, 2026 - Principal Financial Group Inc filed a 13F-HR form disclosing ownership of 418,731 shares of Innoviva, Inc. (DE:HVE) valued at $8,374,620 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 2, 2026 disclosing 339,106 shares of Innoviva, Inc.. This represents a change in shares of 23.48% during the quarter. The current value of the position is $8,039,635 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-04 2026-03-31 13F INNOVIVA COM 45781M101 418,731 79,625 23.48 9,756 43.94 0.0027
2026-02-02 2025-12-31 13F INNOVIVA COM 45781M101 339,106 49,381 17.04 6,779 28.20 0.0035
2025-11-04 2025-09-30 13F INNOVIVA COM 45781M101 289,725 -23,975 -7.64 5,287 -16.11 0.0027
2025-08-08 2025-06-30 13F INNOVIVA COM 45781M101 313,700 8,224 2.69 6,302 13.80 0.0033
2025-04-28 2025-03-31 13F INNOVIVA COM 45781M101 305,476 7,700 2.59 5,538 7.20 0.0031
2025-01-31 2024-12-31 13F INNOVIVA COM 45781M101 297,776 10,999 3.84 5,166 -6.70 0.0028
2024-10-31 2024-09-30 13F INNOVIVA COM 45781M101 286,777 -20,058 -6.54 5,538 10.04 0.0031
2024-07-29 2024-06-30 13F INNOVIVA COM 45781M101 306,835 -17,156 -5.30 5,032 1.92 0.0030
2024-04-29 2024-03-31 13F INNOVIVA COM 45781M101 323,991 313,775 3,071.41 4,938 11,941.46 0.0029
2024-02-07 2023-12-31 13F THESEUS PHARMACEUTICALS COM 88369M101 10,216 -463 -4.34 41 46.43 0.0000
2024-02-07 2023-12-31 13F INNOVIVA COM 45781M101 322,870 -7,607 5,179 0.0018
2023-11-02 2023-09-30 13F THESEUS PHARMACEUTICALS COM 88369M101 10,679 0 0.00 29 -71.72 0.0000
2023-11-02 2023-09-30 13F INNOVIVA COM 45781M101 330,477 -19,073 4,293 0.0031
2023-08-07 2023-06-30 13F THESEUS PHARMACEUTICALS COM 88369M101 10,679 -381,318 -97.28 100 -97.75 0.0001
2023-08-07 2023-06-30 13F INNOVIVA COM 45781M101 349,550 -42,447 4,450 0.0030
2023-05-09 2023-03-31 13F INNOVIVA COM 45781M101 391,997 -10,829 -2.69 4,410 -17.39 0.0032
2023-02-09 2022-12-31 13F INNOVIVA COM 45781M101 402,826 -14,984 -3.59 5,337 10.02 0.0040
2022-11-09 2022-09-30 13F INNOVIVA COM 45781M101 417,810 -53,166 -11.29 4,851 -30.22 0.0039
2022-08-10 2022-06-30 13F INNOVIVA COM 45781M101 470,976 -26,007 -5.23 6,952 -27.71 0.0051
2022-05-09 2022-03-31 13F INNOVIVA COM 45781M101 496,983 -36,861 -6.90 9,617 4.43 0.0038
2022-02-09 2021-12-31 13F INNOVIVA COM 45781M101 533,844 -12,739 -2.33 9,209 0.83 0.0055
2021-11-09 2021-09-30 13F INNOVIVA COM 45781M101 546,583 -9,504 -1.71 9,133 22.48 0.0060
2021-08-10 2021-06-30 13F INNOVIVA COM 45781M101 556,087 -15,346 -2.69 7,457 9.20 0.0048
2021-05-10 2021-03-31 13F INNOVIVA COM 45781M101 571,433 6,388 1.13 6,829 -2.46 0.0048
2021-02-23 2020-12-31 13F/A-1 INNOVIVA COM 45781M101 565,045 29,394 5.49 7,001 25.06 0.0052
2021-02-08 2020-12-31 13F INNOVIVA COM 45781M101 565,045 29,394 7,001 2,754.3013
2020-11-06 2020-09-30 13F INNOVIVA COM 45781M101 535,651 -19,814 -3.57 5,598 -27.91 0.0047
2020-08-05 2020-06-30 13F INNOVIVA COM 45781M101 555,465 8,614 1.58 7,765 20.74 0.0069
2020-05-12 2020-03-31 13F INNOVIVA COM 45781M101 546,851 -20,808 -3.67 6,431 -19.99 0.0071
2020-02-05 2019-12-31 13F INNOVIVA COM 45781M101 567,659 -35,692 -5.92 8,038 26.40 0.0067
2019-11-13 2019-09-30 13F INNOVIVA COM 45781M101 603,351 -12,383 -2.01 6,359 -29.07 0.0056
2019-08-12 2019-06-30 13F INNOVIVA COM 45781M101 615,734 11,701 1.94 8,965 5.79 0.0081
2019-05-10 2019-03-31 13F INNOVIVA COM 45781M101 604,033 -3,857 -0.63 8,474 -20.11 0.0079
2019-02-14 2018-12-31 13F INNOVIVA COM 45781M101 607,890 6,266 1.04 10,607 15.68 0.0113
2018-11-14 2018-09-30 13F INNOVIVA COM 45781M101 601,624 26,131 4.54 9,169 15.45 0.0081
2018-08-13 2018-06-30 13F INNOVIVA COM 45781M101 575,493 -27,825 -4.61 7,942 -21.03 0.0073
2018-05-14 2018-03-31 13F INNOVIVA COM 45781M101 603,318 -9,645 -1.57 10,057 15.62 0.0097
2018-02-12 2017-12-31 13F INNOVIVA COM 45781M101 612,963 -7,542 -1.22 8,698 -0.72 0.0080
2017-11-02 2017-09-30 13F INNOVIVA COM 45781M101 620,505 -22,739 -3.54 8,761 6.41 0.0085
2017-08-08 2017-06-30 13F INNOVIVA COM 45781M101 643,244 7,300 1.15 8,233 -6.39 0.0083
2017-05-11 2017-03-31 13F INNOVIVA COM 45781M101 635,944 35,057 5.83 8,795 36.78 0.0106
2017-02-13 2016-12-31 13F INNOVIVA COM 45781M101 600,887 587,254 4,307.59 6,430 4,186.67 0.0082
2016-11-10 2016-09-30 13F INNOVIVA COM 45781M101 13,633 -4,774 -25.94 150 -22.68 0.0002
2016-08-09 2016-06-30 13F INNOVIVA COM 45781M101 18,407 6,956 60.75 194 34.72 0.0003
2016-05-10 2016-03-31 13F INNOVIVA COM 45781M101 11,451 -3,159 -21.62 144 -6.49 0.0002
2016-02-09 2015-12-31 13F THERAVANCE COM 88338T104 14,610 168 1.16 154 48.08 0.0002
2015-11-12 2015-09-30 13F/A-1 THERAVANCE COM 88338T104 14,442 3,261 29.17 104 -48.51 0.0002
2015-11-09 2015-09-30 13F THERAVANCE COM 88338T104 14,442 104
2015-08-10 2015-06-30 13F THERAVANCE COM 88338T104 11,181 -1,181 -9.55 202 4.12 0.0003
2015-05-14 2015-03-31 13F/A-1 THERAVANCE COM 88338T104 12,362 -154 -1.23 194 9.60 0.0003
2015-05-12 2015-03-31 13F THERAVANCE COM 88338T104 12,362 194
2015-02-12 2014-12-31 13F THERAVANCE COM 88338T104 12,516 -4,080 -24.58 177 -37.68 0.0003
2014-11-13 2014-09-30 13F THERAVANCE COM 88338T104 16,596 2,339 16.41 284 -33.18 0.0005
2014-08-12 2014-06-30 13F THERAVANCE COM 88338T104 14,257 14,257 425 0.0007
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.